-
International Journal of Nanomedicine
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Naphthalocyanine-reconstituted LDL nanoparticles for in vivo cancer imaging and treatment
(2378) Views (555) Full article downloads
Authors: Liping Song, Hui Li, Ulas Sunar, Juan Chen, Ian Corbin
Published Date January 2007
Volume 2007:2(4) Pages 767 - 774
DOI: http://dx.doi.org/10.2147/IJN.S
Liping Song1,2, Hui Li2, Ulas Sunar3, Juan Chen2,4, Ian Corbin2,4, Arjun G Yodh3, Gang Zheng2,4
1Department of Chemistry, Shanghai University, China; 2Department of Radiology and 3Department of Physics and Astronomy, University of Pennsylvania, USA; 4Department of Medical Biophysics, University of Toronto, Ontario, Canada; Division of Biophysics and Bioimaging, Ontario Cancer Institute, Canada
Abstract: Low density lipoproteins (LDLs) are naturally occurring nanoparticles that are biocompatible, biodegradable and non-immunogenic. Moreover, the size of LDL particle is precisely controlled (∼22 nm) by its apoB-100 component, setting them apart from liposomes and lipid micelles. LDL particles have long been proposed as a nanocarrier for targeted delivery of diagnostics and therapeutics to LDL receptor (LDLR)-positive cancers. Here, we report the design and synthesis of a novel naphthalocyanine (Nc)-based photodynamic therapy (PDT) agent, SiNcBOA, and describe its efficient reconstitution into LDL core (100:1 payload). Possessing a near-infrared (NIR) absorption wavelength (>800 nm) and extremely high extinction coefficient (>105 M–1cm–1), SiNcBOA holds the promise of treating deeply seated tumors. Reconstituted LDL particles (r-Nc-LDL) maintain the size and shape of native LDL as determined by transmission electron microscopy, and also retain their LDLR-mediated uptake by cancer cells as demonstrated by confocal microscopy. Its preferential uptake by tumor vs normal tissue was confirmed in vivo by noninvasive optical imaging technique, demonstrating the feasibility of using this nanoparticle for NIR imaging-guided PDT of cancer.
Keywords: naphthalocyanine, lipoproteins, photodynamic therapy, near-infrared optical imaging, nanoparticle, drug delivery
Readers of this article also read:
Formation of potential titanium antigens based on protein binding to titanium dioxide nanoparticles
Evidence-based decision-making within the context of globalization: A “Why–What–How” for leaders and managers of health care organizations
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles
Investigation of endocytosis and cytotoxicity of poly-d, l-lactide-poly(ethylene glycol) micro/nano-particles in osteoblast cells
Galactosylated poly(ethylene glycol)-b-poly(l-lactide-co-ß-malic acid) block copolymer micelles for targeted drug delivery: preparation and in vitro characterization
Amino acid-responsive Crohn's disease: a case study
Comparison of two treatments for coxarthrosis: local hyperthermia versus radio electric asymmetrical brain stimulation
Radio electric asymmetric brain stimulation in the treatment of behavioral and psychiatric symptoms in Alzheimer disease
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Interested in being a peer-reviewer?
Click here to register.
- Display new articles on your site
Use our widget to show articles on your own site
- Applications of gold nanoparticles in cancer nanotechnology
- Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer
- Gold nanoparticles: From nanomedicine to nanosensing
- Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases




